ASIA unversity:Item 310904400/2927
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 94286/110023 (86%)
Visitors : 21658152      Online Users : 476
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/2927


    Title: Innovation Policy-making and Activities in the Biopharmaceutical Industry ?Case of the Developed Countries and Taiwan
    Authors: Yang Hsiu-Chi
    Contributors: Department of International Business
    Keywords: Biopharmaceutical;Innovation;Innovation Policy
    Date: 2004
    Issue Date: 2009-11-16 11:33:23 (UTC+0)
    Publisher: Asia University
    Abstract: The biopharmaceutical industry is an innovative sector of industry and is considered to have high potential for creating added value and hi-tech competitiveness. However, at the same time, the industry?s long product development cycles, technological complexity, high costs and risks demand highly efficient innovation and R&D strategies. The attractiveness of a country can only be maintained by continuous research and innovative efforts. The biopharmaceutical industry can only defend its international position by building innovative potential.
    According to this research, research and innovation activities in the performance of biopharmaceutical industry definitely impact on the development of the industry, and moreover, the government?s innovation policies also play important roles. Government can use the innovation policies to booming and steering the industrial development. After comparing with the other developed countries?the US, EU, and Japan etc.?, we find the infrastructure of the biopharmaceutical industry in Taiwan is inadequate, and the developmental level of this industry still also belongs to an initial stage. Therefore, by exploring other country''s innovation policy, the goal of this research tries to call upon government to make more incentive policies by means of policy learning, in order to lead our country into a highly developed country with biotechnology sector.
    Appears in Collections:[Department of International Business] Theses & dissertations

    Files in This Item:

    File SizeFormat
    0KbUnknown505View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback